News & Articles

Two new studies reveal how antibodies against the SARS-CoV-2 virus can vary between individuals

The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance

The latest discoveries show potential in resolving persistent challenges in healthcare and lab testing for women

Chemomab’s CM-101 is a first-in-class, CCL24-neutralizing monoclonal antibody expected to enter a Phase 2 clinical trial in SSc patients early next year

Watch world-leading scientists online, October 5, to discover the latest tools and techniques advancing Alzheimer's research, single cell characterization, biomarker discovery and more

The three new respiratory test panels on cobas 6800/8800 Systems in CE markets will help identify multiple pathogens with overlapping symptoms in patients

Prof. Akiko Iwasaki explores the differences in the immune responses of COVID-19 patients with moderate and severe disease

A large proportion of patients with impaired immune systems mount a low, or undetectable, immune response after two doses of COVID-19 vaccine

Scientists are recommending that a ‘booster’ dose of the Covid-19 vaccine can protect against variants

Industry expert John Radke reveals how a reliable and transparent supply chain partner can be critical to weathering turbulent times

TSKgel S-type columns have paved the way for an entire suite of columns in nearly every mode of liquid chromatography

New blood test is designed to reduce the number of false positive results and provide improved diagnostic guidance in Systemic Lupus Erythematosus

Fusion Antibodies and Eurofins Discovery sign co-marketing agreement to support timely and cost-effective development of innovative products for the benefit of global healthcare.

Sengenics CSO and inventor of the KREX™ protein folding technology, Professor Jonathan Blackburn, discusses the applications of KREX™ for the discovery of autoantibody-based companion diagnostics and early disease detection biomarkers, as well as the potential benefits in the treatment of autoimmune disease, cancer, neurological and infectious diseases and beyond

QIAreach SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, provides accurate and objective results in 2 to 15 minutes

Dr. Tullia Bruno shares her multi-omics approach to investigating the role of B cells and tertiary lymphoid structures in the quest for novel cancer therapies

The partnership between Fusion Antibodies and BioTickle delivers value with proprietary antibody discovery, engineering and cell line technologies

Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells